The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial ; volume:15 ; number:1 ; day:4 ; month:11 ; year:2014 ; pages:1-9 ; date:12.2014
Trials ; 15, Heft 1 (4.11.2014), 1-9, 12.2014
- Creator
-
Davey, Christopher G.
- Contributor
-
Chanen, Andrew M.
Cotton, Sue M.
Hetrick, Sarah E.
Kerr, Melissa J.
Berk, Michael
Dean, Olivia M.
Yuen, Kally
Phelan, Mark
Ratheesh, Aswin
Schäfer, Miriam R.
Amminger, G Paul
Parker, Alexandra G.
Piskulic, Danijela
Harrigan, Susy
Mackinnon, Andrew J.
Harrison, Ben J.
Mcgorry, Patrick D.
SpringerLink (Online service)
- DOI
-
10.1186/1745-6215-15-425
- URN
-
urn:nbn:de:1111-2016050238329
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Davey, Christopher G.
- Chanen, Andrew M.
- Cotton, Sue M.
- Hetrick, Sarah E.
- Kerr, Melissa J.
- Berk, Michael
- Dean, Olivia M.
- Yuen, Kally
- Phelan, Mark
- Ratheesh, Aswin
- Schäfer, Miriam R.
- Amminger, G Paul
- Parker, Alexandra G.
- Piskulic, Danijela
- Harrigan, Susy
- Mackinnon, Andrew J.
- Harrison, Ben J.
- Mcgorry, Patrick D.
- SpringerLink (Online service)
Other Objects (12)
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Food policies for physical and mental health
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Moving towards a population health approach to the primary prevention of common mental disorders
Tobacco smoking predicts depression and poorer quality of life in heart disease
Lifestyle medicine for depression
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
Emerging pharmacotherapy for cancer patients with cognitive dysfunction
Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Food policies for physical and mental health
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Moving towards a population health approach to the primary prevention of common mental disorders
Tobacco smoking predicts depression and poorer quality of life in heart disease
Lifestyle medicine for depression
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
Emerging pharmacotherapy for cancer patients with cognitive dysfunction
Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Food policies for physical and mental health
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Moving towards a population health approach to the primary prevention of common mental disorders
Tobacco smoking predicts depression and poorer quality of life in heart disease
Lifestyle medicine for depression
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
Emerging pharmacotherapy for cancer patients with cognitive dysfunction
Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences